Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nevro Corp.

www.nevro.com

Latest From Ablynx NV

Ablynx Adds Sanofi To Its List Of Big Pharma Partners

Sanofi is the latest big pharma, following on from Merck & Co., AbbVie and others, to team up with Belgian Nanobody drug developer Ablynx.

Deals Immune Disorders

Pipeline Watch: Top-Line Phase III Canakinumab, Shingrix And Brolucizumab Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Pipeline Watch: Phase III Starts For Seres' SER-109, Leo's Tralokinumab And Alkermes' ALKS-5461

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Appointments: Tiziana, Ergomed, Kymab, Crescendo, Ablynx, Axcella and Alexion.

This week's roundup includes CEO appointments by Tiziana and Ergomed and executive appointments by Crescendo Biologics, Ablynx, Alexion and Axcella. In addition to this, Oxford BioTherapeutics and Kymab have announced board appointments.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • NBI Development Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nevro Corp.
  • Senior Management
  • Michael DeMane, PhD, Chmn. & CEO
    Andrew Galligan, CFO
    Michael Enxing, VP, Sales & Mktg.
    David Caraway, MD, PhD, CMO
    Bradford E Gliner, VP, Clin. & Reg. Affairs
    Patrick Schmitz, VP, Operations
    Andre Walker, SVP, R&D
  • Contact Info
  • Nevro Corp.
    Phone: (650) 251-0005
    1800 Bridge Parkway
    Redwood City, CA 94065
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register